Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Medicus Pharma Ltd.

Get SEC filing alerts via email and in your feed for Medicus Pharma Ltd.

MDCX MDCXW

Medicus Pharma Ltd.

About Medicus Pharma Ltd.

Medicus Pharma Ltd. is a biotech company developing innovative therapies for non-melanoma skin cancers, primarily basal cell carcinoma. Through its subsidiary SkinJect, it focuses on dissolvable microneedle arrays delivering targeted chemotherapeutics like doxorubicin. The company advances clinical programs, leveraging proprietary drug-device combinations regulated by the FDA, aiming to provide non-surgical, localized treatment options with potential for improved safety and efficacy.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Medicus Pharma Ltd.

1
1
Medicus Pharma Ltd. Medicus Pharma Reports $9.04 Million Net Loss in Q1 2026, Increases Operating Expenses

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
Medicus Pharma Ltd. Medicus Pharma Reports $35.4 Million Net Loss and Strategic Acquisitions in 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Medicus Pharma Ltd. Medicus Pharma Reports $20.9 Million Net Loss in Latest Quarter, Highlights Acquisition of Antev Limited

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Medicus Pharma Ltd. Medicus Pharma Reports $6.18 Million Net Loss in Q2 2025, Increases Operating Expenses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Medicus Pharma Ltd. Medicus Pharma Reports Increased Losses of $5.1 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Medicus Pharma Ltd. Medicus Pharma Reports $11.2 Million Net Loss and Significant R&D Investment in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments